<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03908086</url>
  </required_header>
  <id_info>
    <org_study_id>RA-SAB2018</org_study_id>
    <nct_id>NCT03908086</nct_id>
  </id_info>
  <brief_title>Bloodstream Infections in Patients With Rheumatoid Arthritis</brief_title>
  <official_title>Incidence and Risk Factors of Staphylococcus Aureus Bacteremia in Patients With Rheumatoid Arthritis Compared With the General Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sabine Dieperink</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Statens Serum Institut</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <brief_summary>
    <textblock>
      Study of incidence and risk factors of staphylococcus aureus bacteremia in patients with
      rheumatoid arthritis compared with the general population in a nationwide cohort of all adult
      members of the population from 1996 until 2017 using national registries
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 31, 1996</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of staphylococcus aureus bacteremia</measure>
    <time_frame>0-21 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence rate ratios</measure>
    <time_frame>0-21 years</time_frame>
    <description>Comparing rheumatoid arthritis patients with the general population</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk factors of staphylococcus aureus bacteremia</measure>
    <time_frame>0-21 years</time_frame>
    <description>Identification of risk factors both universal to both the general population and rheumatoid arthritis (RA) cohorts and RA disease specific factors (disease duration, disease activity, smoking, joint erosions, etc.)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">6000000</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Staphylococcus Aureus Bacteremia</condition>
  <arm_group>
    <arm_group_label>RA patients</arm_group_label>
    <description>Incident patients with rheumatoid arthritis as identified by the Danish National Patient Registry and the rheumatology registry, DANBIO.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General population</arm_group_label>
    <description>All other adults, as Identified by the Civil Registration System. Patients who develop RA contribute person-years in the general population cohort until RA diagnosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Risk factors in RA cohort</intervention_name>
    <arm_group_label>RA patients</arm_group_label>
    <other_name>DMARDs (biologic and synthetic)</other_name>
    <other_name>Corticosteroids</other_name>
    <other_name>RA disease activity</other_name>
    <other_name>RA disease duration</other_name>
    <other_name>Tobacco use</other_name>
    <other_name>Joint erosions</other_name>
    <other_name>Prosthetic joints</other_name>
    <other_name>Other comorbid conditions and surgical/dialysis procedures</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Risk factors in general population</intervention_name>
    <arm_group_label>General population</arm_group_label>
    <other_name>Prosthetic joints</other_name>
    <other_name>Other comorbid conditions and surgical/dialysis procedures</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All individuals alive and living in Denmark on December 31, 1996 as identified by the Civil
        Registration System are included. Individuals are dynamically included during the study
        period if they immigrate or turn 18. Individuals are followed up until first-time SAB,
        death, emigration or December 31, 2017, whichever comes first.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All members of the adult Danish population

        Exclusion Criteria:

          -  Staphylococcus aureus bacteremia prior to inclusion.

          -  Rheumatoid arthritis diagnosed prior to inclusion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 3, 2019</study_first_submitted>
  <study_first_submitted_qc>April 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2019</study_first_posted>
  <last_update_submitted>April 5, 2019</last_update_submitted>
  <last_update_submitted_qc>April 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Sabine Dieperink</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacteremia</mesh_term>
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

